IQOS marketing in the US: The need to study the impact of FDA modified exposure authorization, marketing distribution channels, and potential targeting of consumers

Carla J. Berg*, Lorien C. Abroms, Hagai Levine, Katelyn F. Romm, Amal Khayat, Christina N. Wysota, Zongshuan Duan, Yael Bar-Zeev

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'IQOS marketing in the US: The need to study the impact of FDA modified exposure authorization, marketing distribution channels, and potential targeting of consumers'. Together they form a unique fingerprint.

Social Sciences

Keyphrases